Co-Irbesartan Sandoz 150/12

Co-Irbesartan Sandoz 150/12 is a medicine authorised by Swissmedic under authorisation number 62640. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 06 November 2012 and the authorisation is valid without a time limit. ATC code C09DA04 places the medicine in the group Agents acting on the renin-angiotensin system.

  • Dispensing category B
  • Authorisation number 62640
  • ATC C09DA04
  • Synthetic medicines
Authorisation data
Authorisation number62640
NameCo-Irbesartan Sandoz 150/12
Full nameCo-Irbesartan Sandoz 150/12,5 mg, Filmtabletten
Authorisation holderSandoz Pharmaceuticals AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeC09DA04
First authorisation06 November 2012
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Co-Irbesartan Sandoz 150/12,5 mg, FilmtablettenB06 November 2012
2Co-Irbesartan Sandoz 300/12,5 mg, FilmtablettenB06 November 2012
3Co-Irbesartan Sandoz 300/25 mg, FilmtablettenB06 November 2012

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
128Tablette(n)C09DA0402.07.2.B
298Tablette(n)C09DA0402.07.2.B
328Tablette(n)C09DA0402.07.2.B
498Tablette(n)C09DA0402.07.2.B
528Tablette(n)C09DA0402.07.2.B
698Tablette(n)C09DA0402.07.2.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Co-Irbesartan Sandoz 150/12 authorised in Switzerland?

Yes. Co-Irbesartan Sandoz 150/12 is authorised by Swissmedic under authorisation number 62640, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Co-Irbesartan Sandoz 150/12 have?

Co-Irbesartan Sandoz 150/12 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Co-Irbesartan Sandoz 150/12?

The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com